Literature DB >> 10908037

High susceptibility to cerebral ischemia in GFAP-null mice.

H Nawashiro1, M Brenner, S Fukui, K Shima, J M Hallenbeck.   

Abstract

Astrocytes perform a variety of functions in the adult central nervous system (CNS) that contribute to the survival of neurons. Thus, it is likely that the activities of astrocytes affect the extent of brain damage after ischemic stroke. The authors tested this hypothesis by using a mouse ischemia model to compare the infarct volume produced in wild-type mice with that produced in mice lacking glial fibrillary acidic protein (GFAP), an astrocyte specific intermediate filament component. Astrocytes lacking GFAP have been shown to have defects in process formation, induction of the blood-brain barrier. and volume regulation; therefore, they might be compromised in their ability to protect the CNS after injury. The authors reported here that 48 hours after combined permanent middle cerebral artery occlusion (MCAO) and 15 minutes transient carotid artery occlusion (CAO) GFAP-null mice had a significantly (P < 0.001) larger cortical infarct volume (16.7 +/- 2.2 mm3) than their wild-type littermates (10.1 +/- 3.9 mm3). Laser-Doppler flowmetry revealed that the GFAP-null mice had a more extensive and profound decrease in cortical cerebral blood flow within 2 minutes after MCAO with CAO. These results indicated a high susceptibility to cerebral ischemia in GFAP-null mice and suggested an important role for astrocytes and GFAP in the progress of ischemic brain damage after focal cerebral ischemia with partial reperfusion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10908037     DOI: 10.1097/00004647-200007000-00003

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  43 in total

1.  Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.

Authors:  Hironori Yokoyama; Ryohei Yano; Hayato Kuroiwa; Tatsuya Tsukada; Hiroto Uchida; Hiroyuki Kato; Jiro Kasahara; Tsutomu Araki
Journal:  Metab Brain Dis       Date:  2010-04-28       Impact factor: 3.584

Review 2.  Astrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke.

Authors:  Zhongwu Liu; Michael Chopp
Journal:  Prog Neurobiol       Date:  2015-10-09       Impact factor: 11.685

3.  Pharmacological inhibition of pleckstrin homology domain leucine-rich repeat protein phosphatase is neuroprotective: differential effects on astrocytes.

Authors:  Travis C Jackson; Jonathan D Verrier; Tomas Drabek; Keri Janesko-Feldman; Delbert G Gillespie; Thomas Uray; Cameron Dezfulian; Robert S Clark; Hülya Bayir; Edwin K Jackson; Patrick M Kochanek
Journal:  J Pharmacol Exp Ther       Date:  2013-09-10       Impact factor: 4.030

4.  Damage to oligodendrocytes in the striatum after MPTP neurotoxicity in mice.

Authors:  S Takagi; N Hayakawa; H Kimoto; H Kato; T Araki
Journal:  J Neural Transm (Vienna)       Date:  2007-08-06       Impact factor: 3.575

Review 5.  Mechanisms of ischemic brain damage.

Authors:  Kristian P Doyle; Roger P Simon; Mary P Stenzel-Poore
Journal:  Neuropharmacology       Date:  2008-01-25       Impact factor: 5.250

6.  Proteasome inhibitor does not enhance MPTP neurotoxicity in mice.

Authors:  Naoto Kadoguchi; Masahiro Umeda; Hiroyuki Kato; Tsutomu Araki
Journal:  Cell Mol Neurobiol       Date:  2008-03-14       Impact factor: 5.046

Review 7.  Modulation of Synaptic Plasticity by Exercise Training as a Basis for Ischemic Stroke Rehabilitation.

Authors:  Jingjing Nie; Xiaosu Yang
Journal:  Cell Mol Neurobiol       Date:  2016-02-24       Impact factor: 5.046

Review 8.  Neuroimmune Response in Ischemic Preconditioning.

Authors:  Ashley McDonough; Jonathan R Weinstein
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

9.  Protective role of phosphorylation in turnover of glial fibrillary acidic protein in mice.

Authors:  Masaaki Takemura; Hiroshi Gomi; Emma Colucci-Guyon; Shigeyoshi Itohara
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

10.  Overexpression of human S100B exacerbates brain damage and periinfarct gliosis after permanent focal ischemia.

Authors:  Takashi Mori; Jun Tan; Gary W Arendash; Naoki Koyama; Yoshiko Nojima; Terrence Town
Journal:  Stroke       Date:  2008-05-01       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.